Pharmaceutical Drug Targets and Diseases: Difference between revisions
No edit summary |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 29: | Line 29: | ||
**Autoimmune Diseases | **Autoimmune Diseases | ||
***[[Prolyl Endopeptidase]] | ***[[Prolyl Endopeptidase]] | ||
***[[Tumor | ***[[Tumor necrosis factor receptor]] | ||
***[[Molecular_Playground/TRAIL|Tumor-Necrosis Factor Apoptosis-Inducing Ligand]] | ***[[Molecular_Playground/TRAIL|Tumor-Necrosis Factor Apoptosis-Inducing Ligand]] | ||
| Line 88: | Line 88: | ||
*** Poliovirus | *** Poliovirus | ||
****[[Journal:PLoS ONE:1|Antiviral Activity of 3(2H)- and 6-Chloro-3(2H)-Isoflavenes against Highly Diverged, Neurovirulent Vaccine-Derived, Type2 Poliovirus Sewage Isolates]] | ****[[Journal:PLoS ONE:1|Antiviral Activity of 3(2H)- and 6-Chloro-3(2H)-Isoflavenes against Highly Diverged, Neurovirulent Vaccine-Derived, Type2 Poliovirus Sewage Isolates]] | ||
*** [[Interferon]] | |||
}} | }} | ||
See [[Pharmaceutical Drugs]] for descriptions and analysis of well known drugs | See [[Pharmaceutical Drugs]] for descriptions and analysis of well known drugs | ||